Drug Profile
Breast disorders therapeutic - China Sky One Medical
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Harbin Medical University
- Developer China Sky One Medical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Breast disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Breast-disorders in China
- 28 Oct 2008 Phase-I clinical trials in Breast disorders in China (unspecified route)